The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
2015 ◽
Vol 29
(9)
◽
pp. 1811-1822
◽
K Balakrishnan
◽
M Peluso
◽
M Fu
◽
N Y Rosin
◽
J A Burger
◽
...
2011 ◽
Vol 11
◽
pp. S178-S179
Stephen E. Spurgeon
◽
Luke B. Fletcher
◽
Sarah Meadows
◽
Brian Lannutti
◽
Russell T. Burke
◽
...
2021 ◽
Vol 127
(5)
◽
pp. S103
2007 ◽
Vol 74
(1)
◽
pp. 47
◽
Hsiangling Teo
◽
David J. Gill
◽
Ji Sun
◽
Olga Perisic
◽
Dmitry B. Veprintsev
◽
...
2004 ◽
Vol 46
(1)
◽
pp. 37-46
Yasutaka Azuma
◽
Kyoko Watanabe
◽
Masataka Date
◽
Shinya Shirasu
◽
Michiharu Daito
◽
...
Close
Export Citation Format
Close
Share Document
Close